Health Condition 1: M859- Disorder of bone density and structure, unspecified Health Condition 2: M159- Polyosteoarthritis, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients of both sexes, irrespective of religion , habitat, income status, occupation ,etc. 2.Age between 40 years to 70 years 3.Patients with Primary Osteoarthritis-knee joint{single or both knee} 3.Patients willing to include themselves in the study through informed consent form. 4.kellgren lawrence (Radiologicalscale 2)
Exclusion criteria
Exclusion criteria: 1.Patients having age between 40 - 70 years. 2.Patients suffering with disease like cardiac problem, diabetes mellitus, hepatic disorder, renal disease, malignancies, pregnant mother etc. 3.Patients who are currently participating in any other clinical trial. 4.Patients with skin allergies/ skin skin disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The primary outcome will be measured based on clinical outcome, Radiological outcome Hematological outcome, Bio-chemical outcome measures, Safety and tolerability outcome measure to determine the effectiveness and safety of the test drug for the treatment of Sandhigatavata (Osteoarthritis)Timepoint: 56 days(8 weeks) | — |
Secondary
| Measure | Time frame |
|---|---|
| The effects of the test drug medication alters the quality of life that will be evaluated after completion of the treatment.Timepoint: 56 days(8 weeks) | — |
Countries
India
Contacts
Institute of Post Graduate Ayurvedic Education and Research at SVSP Hospital